Visit-to-visit variability in systolic blood pressure: Correlated with the changes of arterial stiffness and myocardial perfusion in on-treated hypertensive patients

Clinical and Experimental Hypertension

Volumn 37, Issue 1, 2015, Pages 63-69

  Song, Hongbin ^a   Wei, Fang ^b   Liu, Zhendong ^a   Zhao, Yingxin ^a   Ye, Lin ^c   Lu, Fanghong ^a   Zhang, Hua ^a   Diao, Yutao ^a   Qi, Zaiwen ^a   Xu, Jianchao ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b JINAN CENTRAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Antihypertension; Artery stiffness; Blood pressure variability; Myocardial perfusion; Pulse wave velocity

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CAROTID ARTERY PULSE; CORRELATION ANALYSIS; FEMALE; HEART MUSCLE PERFUSION; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PULSE WAVE; SYSTOLIC BLOOD PRESSURE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAROTID ARTERY; DRUG EFFECTS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CAROTID ARTERIES; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84921291600     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2014.897724     Document Type: Article

References (35)

1. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895-905.
2. Rothwell PM, Howard SC, Dolan E, et al. Effect of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke. Lancet Neurol 2010;9:469-80.
3. Yokota K, Fukuda M, Matsui Y, et al. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res 2013;36:151-7.
4. Kawai T, Ohishi M, Kamide K, et al. The impact of visit-to-visit variability in blood pressure on renal function. Hypertens Res 2012;35:239-43.
5. Nagai M, Hoshide S, Ishikawa J, et al. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 2011;5:184-92.
6. Nagai M, Hoshide S, Ishikawa J, et al. Visit-to-visit blood pressure variations: new independent determinants for cognitive function in the elderly at high risk of cardiovascular disease. J Hypertens 2012;30:1556-63.
7. Howard SC, Rothwell PM. Reproducibility of measures of visit-tovisit variability in blood pressure after transient ischaemic attack or minor stroke. Cerebrovasc Dis 2009;28:331-40.
8. Paul M, Joyce C, Levitan EB, et al. Reproducibilty of visit-to-visit variability of blood pressure measured as part of routine clinical care. J Hypertens 2011;29:2332-8.
9. Salvi P, Revera M, Faini A, et al. Changes in subendocardial viability ratio with acute high-altitude exposure and protective role of acetazolamide. Hypertension 2013;61:793-9.
10. Lehmann ED. Clinical value of aortic pulse-wave velocity measurement. Lancet 1999;354:528-9.
11. Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham heart study. Circulation 2010;121:505-11.
12. Maldonado J, Pereira T, Polonia J, et al. Arterial stiffness predicts cardiovascular outcome in a low-to-moderate cardiovascular risk population: the EDIVA (Estudo de DIstensibilidade Vascular) project. J Hypertens 2011;29:669-75.
13. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318-27.
14. Bodlaj G, Berg J, Biesenbach G. Diurnal variation of arterial stiffness and subendocardial perfusion noninvasively assessed using applanation tonometry in healthy young men. Wien Klin Wochenschr 2005;117:348-52.
15. Authors/Task Force Members, Mancia G, Fagard R, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013;34:2159-219.
16. Vlachopoulos C, Aznaouridis K, O'Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010;31:1865-71.
17. Klocke R, Cockcroft JR, Taylor GJ, et al. Arterial stiffness and central blood pressure, as determined by pulse wave analysis, in rheumatoid arthritis. Ann Rheum Dis 2003;62:414-18.
18. Buckberg GD, Fixler DE, Archie JP, Hoffman JI. Experimental subendocardial ischemia in dogs with normal coronary arteries. Circ Res 1972;30:67-81.
19. Merkus D, Kajiya F, Vink H, et al. Prolonged diastolic time fraction protects myocardial perfusion when coronary blood flow is reduced. Circulation 1999;100:75-81.
20. Tsiachris D, Tsioufis C, Syrseloudis D, et al. Subendocardial viability ratio as an index of impaired coronary flow reserve in hypertensive without significant coronary artery stenoses. J Hum Hypertens 2012;26:64-70.
21. Brooks B, Molyneaux L, Yue DK. Augmentation of central arterial pressure in type 1 diabetes. Diabetes Care 1999;22:1722-7.
22. Brooks AB, Molyneaux LM, Yue DK. Augmentation of central arterial pressure in type 2 diabetes. Diabet Med 2001;18:374-80.
23. Wang W, Ma L, Zhang Y, et al. The combination of amlodipine and angiotensin receptor blocker or diuretics in high-risk hypertensive patients: rationale, design and baseline characteristics. J Hum Hypertens 2011;25:271-7.
24. Lu F, Zhao Y, Liu Z, et al. A 48-week study of amlodipine plus amiloride/hydrochlorothiazide vs. amlodipine plus telmisartan in the treatment of hypertension. Int J Clin Pract 2012;66:792-9.
25. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: method, validity, and applications. J Clin Epidemiol 1997;50:105-16.
26. Muntner P, Shimbo D, Tonelli M, et al. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011;57:160-6.
27. Rossignol P, Cridlig J, Lehert P, et al. Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL. Hypertension 2012;60:339-46.
28. Okada H, Fukui M, Tanaka M, et al. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012;220:155-9.
29. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation 2012;126:569-78.
30. Krakoff LR. Fluctuation: does blood pressure variability matter? Circulation 2012;126:525-7.
31. Rossignol P, Kessler M, Zannad F. Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseased. Curr Opin Nephrol Hypertens 2013;22:59-64.
32. Burt MG, Mangelsdorf BL, Srivastava D, Petersons CJ. Acute effect of calcium citrate on serum calcium and cardiovascular function. J Bone Miner Res 2013;28:412-18.
33. Hoffman JI, Buckberg GD. The myocardial supply: demand ratio - a critical review. Am J Cardiol 1978;41:327-32.
34. Baller D, Bretschneider HJ, Hellige G. A critical look at currently used indirect indices of myocardial oxygen consumption. Basic Res Cardiol 1981;76:163-81.
35. Eto M, Toba K, Akishita M, et al. Reduced endothelial vasomotor function and enhanced neointimal formation after vascular injury in a rat model of blood pressure lability. Hypertens Res 2003;26:991-8.